2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $385M | $444M | $422M | $445M | $100K |
Cost of Revenue | $101M | $115M | $122M | $124M | $29K |
Gross Profit | $284M | $329M | $300M | $321M | $72K |
Gross Profit % | 74% | 74% | 71% | 72% | 72% |
R&D Expenses | $1.5M | $1.4M | $1.5M | $1.6M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $23M | $30M | $550K | $15M | $7.9M |
Dep. & Amort. | $11M | $11M | $11M | $12M | $14M |
Def. Tax | -$4.4M | -$4.1M | $6.6M | -$8.5M | -$1.7M |
Stock Comp. | $3.8M | $3.7M | $2.9M | $4.9M | $4.8M |
Chg. in WC | $793K | -$15M | -$27M | $13M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $92M | $86M | $60M | $82M | $85M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $92M | $86M | $60M | $82M | $85M |
Receivables | $7.4M | $8.9M | $14M | $8.8M | $9.5M |
Inventory | $48M | $61M | $68M | $67M | $59M |
Nature's Sunshine reported Q4 2024 revenue of $118M ($120M on a constant currency basis), reflecting a 10% year-over-year increase, with adjusted EBITDA of $10M, up 6% year-over-year.
Asia Pacific led growth with a 21% increase in local currency sales, driven by strong performances in Taiwan (+29%), Japan (+27%), and Korea (+21%), while China showed positive sales growth after prior declines.
Digital sales in North America grew 17% in Q4 and 22% for the full year, with plans to roll out advanced AI-powered digital tools for distributors in late 2025 to enhance customer engagement and sales efficiency.
Full-year 2025 guidance includes net sales of $445M-$470M (inclusive of a $5M foreign exchange headwind) and adjusted EBITDA of $38M-$44M, reflecting cautious optimism amid macroeconomic uncertainties and potential tariff impacts.
The company anticipates a $2M-$3M gross margin impact from proposed tariffs, with measures in place to mitigate risks, while maintaining a strong balance sheet with $84.7M in cash and no debt.